Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Olutasidenib met of zonder azacitidine bij IDH1-gemuteerde AML en MDS
feb 2023 | Leukemie, MDS